Michael C Roarke, MD

Quick facts

Phase 2 pipeline

• Fludeoxyglucose PET CT · Oncology
  A positron-emitting glucose analog that accumulates in cancer cells, allowing for PET imaging.
• Fludeoxyglucose PET MRI
• Sodium Acetate C11 PET CT
• Sodium Acetate C11 PET MRI

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Michael C Roarke, MD portfolio CI brief
• Michael C Roarke, MD pipeline updates RSS

Related

• Sector hub: All tracked pharma companies